1-1 of 1
Li-Juan Cui
Close
Sort by
Journal Articles

Effectiveness and Safety of Orelabrutinib Combined with Rituximab As First-Line Treatment in Marginal Zone Lymphoma

Jiadai Xu, Lu-Ya Cheng, Yang Ke, Yi-An Zhang, Li-Juan Cui, Hui Xiao, Yue-Xin Cheng, Peng Liu
Journal: Blood
Blood (2023) 142 (Supplement 1): 6146.
https://doi.org/10.1182/blood-2023-181381
Published: 2023